Washington [US], January 8 (ANI): A recent clinical study has identified sildenafil, FDA-approved therapy for erectile dysfunction and pulmonary hypertension, as a promising drug candidate to treat Alzheimer's disease.
Washington [US], January 3 (ANI): A new study by the Cleveland Clinic has found that sildenafil, an FDA-approved therapy for erectile dysfunction and pulmonary hypertension, is a promising drug candidate to help prevent and treat Alzheimer's disease.
\
\
\
\
